Glyzia Met Tablets 50/500Mg

Glyzia Met 50/500mg Tablet combines sitagliptin 50mg and metformin hydrochloride 500mg to help improve blood-glucose control in adults with type 2 diabetes alongside a diet and physical activity. Sitagliptin is a DPP-4 inhibitor that increases incretin activity, helping the pancreas release insulin when glucose levels are elevated and reducing glucose production by the liver. Metformin lowers hepatic glucose production and improves the body’s response to insulin. Take Glyzia Met exactly as prescribed, usually with meals to reduce stomach-related side effects. Swallow the tablet with water and continue following the recommended diet, exercise, and glucose-monitoring plan. Common side effects include nausea, diarrhoea, abdominal discomfort, reduced appetite, headache, and a metallic taste. Low blood sugar is more likely when it is combined with insulin or a sulfonylurea. Kidney function should be assessed before and during treatment because metformin can rarely cause serious lactic acidosis, particularly in people with severe kidney impairment. Seek urgent medical care for persistent vomiting, severe abdominal pain, unusual weakness, breathing difficulty, or symptoms suggesting pancreatitis. Inform your doctor before contrast imaging, surgery, pregnancy, or starting any additional treatment.

Price: Rs. 260.00

• Manufacturer
  Agp Pharma
• Generic name
  Sitagliptin + Metformin
• Pack size
  1 Box= 2 Strips | 1 Strip= 7 Tablets
• Availability
  In stock
• Prescription required
  No